Capital World Investors Precision Biosciences Inc Transaction History

Capital World Investors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.29 - $0.45 $462,719 - $718,013	-1,595,585 Reduced 23.76%	5,119,458 $1.84 Million
Q2 2022 Aug 15, 2022	BUY	$1.15 - $3.34 $2.81 Million - $8.17 Million	2,446,043 Added 57.3%	6,715,043 $10.7 Million
Q2 2021 Aug 16, 2021	BUY	$8.07 - $12.52 $1.67 Million - $2.59 Million	207,000 Added 5.1%	4,269,000 $53.4 Million
Q4 2019 Feb 18, 2020	BUY	$6.32 - $19.66 $21.7 Million - $67.6 Million	3,437,000 Added 549.92%	4,062,000 $56.4 Million
Q1 2019 May 15, 2019	BUY	$17.44 - $17.95 $10.9 Million - $11.2 Million	625,000 New	625,000 $11.2 Million

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $539M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

Stay updated on Capital World Investors with notifications on news.